Covariate, n (row %) | Sucess | Failure | Total | p-value |
---|---|---|---|---|
Overall | >4741 (85.1) | 767 (13.9) | 5508 | N/A |
Patient age (years) | ||||
<45 | 290 (80.6) | 70 (19.4) | 360 | <0.001 |
45 to 64 | 2549 (88.7) | 324 (11.3) | 2873 | |
65 to 79 | 1642 (84.7) | 297 (15.3) | 1939 | |
≥80 | 260 (77.4) | 76 (22.6) | 336 | |
Patient gender | ||||
Male | 3008 (85.6) | 506 (14.4) | 3514 | 0.177 |
Female | 1733 (86.9) | 261 (13.1) | 1994 | |
Lens status | ||||
No previous cataract surgery | 3151 (87.3) | 460 (12.7) | 3611 | 0.002 |
Previous cataract surgery | 1374 (84.0) | 261 (16.0) | 1635 | |
Combined phaco vitrectomy | 216 (82.4) | 46 (17.6) | 262 | |
Foveal status | ||||
Attached | 2210 (90.1) | 242 (9.9) | 2452 | <0.001 |
Detached | 2519 (82.8) | 522 (17.2) | 3041 | |
Not recorded | 12 (80.0) | 3 (20.0) | 15 | |
Number of breaks in the attached retina | ||||
None | 3359 (84.8) | 601 (15.2) | 3960 | 0.001 |
1 break | 660 (89.4 | 78 (10.6) | 738 | |
2 breaks | 312 (87.6) | 44 (12.4) | 356 | |
3 breaks | 201 (89.3) | 24 (10.7) | 225 | |
>3 breaks | 209 (91.3) | 20 (8.7) | 229 | |
Number of breaks in the detached retina | ||||
None | 14 (82.4) | 3 (17.6) | 17 | 0.008 |
1 break | 2147 (87.5) | 306 (12.5) | 2453 | |
2 breaks | 1113 (85.2) | 194 (14.8) | 1307 | |
3 breaks | 685 (86.9) | 103 (13.1) | 788 | |
>3 breaks | 782 (82.9) | 161 (17.1) | 943 | |
Location of largest break | ||||
9 – 3 O’clock | 3547 (89.0) | 438 (11.0) | 3985 | <0.001 |
4 or 8 O ’clock | 477 (82.7) | 100 (17.3) | 577 | |
5 – 7 O’clock | 703 (75.7) | 226 (24.3) | 929 | |
No break found | 14 (82.4) | 3 (17.6) | 17 | |
Superior clock hours detached | ||||
<3 h | 1558 (86.4) | 245 (13.6) | 1803 | <0.001 |
3 to 5 h | 2673 (88.8) | 338 (11.2) | 3011 | |
6 h | 510 (73.5) | 184 (26.5) | 694 | |
Inferior clock hours detached | ||||
<3 h | 2997 (91.3) | 284 (8.7) | 3281 | <0.001 |
3 to 5 h | 1068 (82.7) | 224 (17.3) | 1292 | |
6 h | 676 (72.3) | 259 (27.7) | 935 | |
Total RD | ||||
No | 4502 (87.9) | 620 (12.1) | 5122 | <0.001 |
Yes | 239 (61.9) | 147 (38.1) | 386 | |
Largest break type | ||||
Not found | 33 (71.7) | 13 (28.3) | 46 | <0.001 |
U tear | 4162 (86.9) | 627 (13.1) | 4789 | |
Round hole | 330 (81.7) | 74 (18.3) | 404 | |
Dialysis | 32 (88.9) | 4 (11.1) | 36 | |
Giant Retinal Tear | 137 (83.0) | 28 (17.0) | 165 | |
Macular hole | 3 (42.9) | 4 (57.1) | 7 | |
Outer leaf break | 44 (72.1) | 17 (27.9) | 61 | |
Schisis RD | ||||
Absent | 4697 (86.2) | 750 (13.8) | 5447 | 0.002 |
Present | 44 (72.1) | 17 (27.9) | 61 | |
PVR grade | ||||
None, A or B | 4456 (88.1) | 602 (11.9) | 5058 | <0.001 |
> = C | 285 (63.3) | 165 (36.7) | 450 | |
Laser photocoagulation used during surgery | ||||
No | 2929 (88.9) | 367 (11.1) | 3296 | <0.001 |
Yes | 1812 (81.9) | 400 (18.1) | 2212 | |
Cryotherapy used during surgery | ||||
No | 764 (78.2) | 213 (21.8) | 977 | <0.001 |
Yes | 3977 (87.8) | 554 (12.2) | 4531 | |
Tamponade used during surgery | ||||
Sulphur hexafluoride gas | 2268 (89.9) | 256 (10.1) | 2524 | <0.001 |
Perfluoroethane gas | 1538 (89.9) | 173 (10.1) | 1711 | |
Perfluoropropane gas | 558 (81.9) | 123 (18.1) | 681 | |
Air | 42 (89.4) | 5 (10.6) | 47 | |
Light oil | 265 (59.3) | 182 (40.7) | 447 | |
Heavy oil | 70 (71.4) | 28 (28.6) | 98 | |
Vitrectomy gauge used | ||||
20 g | 143 (74.5) | 49 (25.5) | 192 | <0.001 |
23 g | 2809 (84.5) | 515 (15.5) | 3324 | |
25 g | 1618 (89.9) | 181 (10.1) | 1799 | |
27 g | 78 (88.6) | 10 (11.4) | 88 | |
Not recorded | 93 (88.6) | 12 (11.4) | 105 | |
Sub-retinal fluid drainage route | ||||
Retinotomy | 755 (84.4) | 140 (15.6) | 895 | 0.266 |
Through the break | 3208 (86.4) | 506 (13.6) | 3,714 | |
None/not recorded/other | 778 (86.5) | 121 (13.5) | 899 | |
Patient post-surgery posture position | ||||
None | 1149 (86.1) | 186 (13.9) | 1335 | 0.640 |
Prone | 1756 (86.2) | 281 (13.8) | 2037 | |
Upright | 1048 (85.1) | 183 (14.9) | 1231 | |
Other | 788 (87.1) | 117 (12.9) | 905 | |
Age-related Macular Degeneration | ||||
Absent | 4704 (86.2) | 750 (13.8) | 5454 | <0.001 |
Present | 37 (68.5) | 17 (31.5) | 54 | |
Amblyopia | ||||
Absent | 4677 (86.2) | 748 (13.8) | 5425 | 0.017 |
Present | 64 (77.1) | 19 (22.9) | 83 | |
Glaucoma | ||||
Absent | 4679 (86.1) | 753 (13.9) | 5432 | 0.254 |
Present | 62 (81.6) | 14 (18.4) | 76 | |
High Myopia | ||||
Absent | 4491 (86.0) | 729 (14.0) | 5220 | 0.713 |
Present | 250 (86.8) | 38 (13.2) | 288 |
Table 1. Univariate analysis of covariates considered for the primary RD surgery failure model.
Covariate | Odds ratio | Coefficient | p-value | 95% CI for the odds ratio |
---|---|---|---|---|
Constant | 0.120 | –1.611 | <0.001 | 0.088 to 0.452 |
Patient age (years) | ||||
45 to 64 | Ref | Ref | N/A | N/A |
65 to 79 | 1.266 | 0.236 | 0.005 | 1.076 to 1.490 |
≥80 | 1.645 | 0.498 | 0.001 | 1.221 to 2.218 |
<45 | 1.583 | 0.459 | 0.004 | 1.154 to 2.171 |
Location of lowest break | ||||
9–3 O’clock | Ref | Ref | N/A | N/A |
4 or 8 O’clock | 1.533 | 0.428 | 0.002 | 1.171 to 2.008 |
5–7 O’clock | 1.835 | 0.607 | <0.001 | 1.505 to 2.237 |
No break found | 1.966 | 0.676 | 0.242 | 0.634 to 6.100 |
Inferior clock hours detached | ||||
<3 h | Ref | Ref | N/A | N/A |
3 to 5 h | 1.554 | 0.441 | <0.001 | 1.259 to 1.918 |
6 h | 1.545 | 0.435 | 0.005 | 1.143 to 2.089 |
Total Rd | ||||
No | Ref | Ref | N/A | N/A |
Yes | 1.941 | 0.663 | <0.001 | 1.411 to 2.668 |
PVR grade | ||||
None, A or B | Ref | Ref | N/A | N/A |
C | 1.247 | 0.220 | <0.001 | 1.133 to 1.372 |
Cryotherapy used during surgery | ||||
No | Ref | Ref | Ref | Ref |
Yes | 0.657 | –0.420 | 0.011 | 0.476 to 0.908 |
Tamponade used during surgery | ||||
Sulphur hexafluoride gas | Ref | Ref | Ref | Ref |
Perfluoroethane gas | 0.659 | –0.417 | 0.006 | 0.490 to 0.887 |
Perfluoropropane gas | 0.901 | –0.104 | 0.473 | 0.678 to 1.198 |
Air | 0.853 | –0.159 | 0.752 | 0.319 to 2.284 |
Light oil | 1.954 | 0.670 | <0.001 | 1.361 to 2.805 |
Heavy oil | 1.031 | 0.030 | 0.931 | 0.522 to 2.037 |
Vitrectomy gauge used | ||||
20 g | Ref | Ref | Ref | Ref |
23 g | 0.665 | –0.408 | 0.258 | 0.327 to 1.349 |
25 g | 0.413 | –0.885 | 0.014 | 0.204 to 0.834 |
27 g | 0.495 | –0.703 | 0.132 | 0.198 to 1.127 |
CELL | 0.478 | –0.738 | 0.123 | 0.187 to 1.223 |
Table 2. Primary RD surgery failure model estimates.
Covariate | SF6 gas | C2F6 gas | C3F8 gas | Air | Light oil | Heavy oil | Overall |
---|---|---|---|---|---|---|---|
Number of operations | 2524 | 1711 | 681 | 47 | 447 | 98 | 5508 |
Patient age (years) | |||||||
45 to 64 | 1399 (55.4) | 910 (53.2) | 328 (48.2) | 18 (38.3) | 182 (40.7) | 36 (36.7) | 2873 (52.2) |
65 to 79 | 886 (35.1) | 582 (34.0) | 249 (36.6) | 12 (25.5) | 165 (36.9) | 45 (45.9) | 1939 (35.2) |
≥80 | 114 (4.5) | 107 (6.3) | 53 (7.8) | 2 (4.3) | 50 (11.2) | 10 (10.2) | 336 (6.1) |
<45 | 125 (5.0) | 112 (6.5) | 51 (7.5) | 15 (31.9) | 50 (11.2) | 7 (7.1) | 360 (6.5) |
Location of largest break | |||||||
9–3 O’clock | 2306 (91.4) | 1110 (64.9) | 266 (39.1) | 29 (61.7) | 253 (56.6) | 21 (21.4) | 3985 (72.3) |
4 or 8 O’clock | 128 (5.1) | 257 (15.0) | 119 (17.5) | 8 (17.0) | 54 (12.1) | 11 (11.2) | 577 (10.5) |
5–7 O’clock | 88 (3.5) | 338 (19.8 | 290 (42.6) | 10 (21.3) | 137 (30.6) | 66 (67.3) | 929 (16.9) |
No break found | 2 (<0.1) | 6 (0.4) | 6 (0.9) | 0 (0.0) | 3 (0.7) | 0 (0.0) | 17 (0.3) |
Inferior clock hours detached | |||||||
<3 h | 1961 (77.7) | 979 (57.2) | 207 (30.4) | 28 (59.6) | 99 (22.1) | 7 (7.1) | 3281 (59.6) |
3–5 h | 357 (14.1) | 492 (28.8) | 266 (39.1) | 16 (34.0) | 112 (25.1) | 49 (50.0) | 1292 (23.5) |
6 h | 206 (8.2) | 240 (14.0) | 208 (30.5) | 3 (6.4) | 236 (52.8) | 42 (42.9) | 935 (17.0) |
Total RD | |||||||
No | 2463 (97.6) | 1630 (95.3) | 594 (87.2) | 47 (100.0) | 297 (66.4) | 91 (92.9) | 5122 (93.0) |
Yes | 61 (2.4) | 81 (4.7) | 87 (12.8) | 0 (0.0) | 150 (33.6) | 7 (7.1) | 386 (7.0) |
PVR grade | |||||||
None, A or B | 2483 (98.4) | 1600 (93.5) | 597 (87.7) | 44 (93.6) | 274 (61.3) | 60 (61.2) | 5058 (91.8) |
C | 41 (1.6) | 111 (6.5) | 84 (12.3) | 3 (6.4) | 173 (38.7) | 38 (38.8) | 450 (8.2 |
Cryotherapy used during surgery | |||||||
No | 372 (14.7) | 315 (18.4) | 89 (13.1) | 2 (4.3) | 160 (35.8) | 39 (39.8) | 977 (17.7) |
Yes | 2152 (85.3) | 1396 (81.6) | 592 (86.9) | 45 (95.7) | 287 (64.2) | 59 (60.2) | 4531 (82.3) |
Vitrectomy gauge used | |||||||
20 g | 97 (3.8) | 30 (1.8) | 23 (3.4) | 0 (0.0) | 32 (7.2) | 10 (10.2) | 192 (3.5) |
23 g | 1298 (51.4) | 1161 (67.9) | 476 (69.9) | 8 (17.0) | 323 (72.3) | 58 (59.2) | 3324 (60.3) |
25 g | 1072 (42.5) | 452 (26.4) | 160 (23.5) | 5 (10.6) | 83 (18.6) | 27 (27.6) | 1799 (32.7) |
27 g | 27 (1.1) | 49 (2.9) | 3 (0.4) | 1 (2.1) | 5 (1.1) | 3 (3.1) | 88 (1.6) |
Not recorded | 30 (1.2) | 19 (1.1) | 19 (2.8) | 33 (70.2) | 4 (0.9) | 0 (0.0) | 105 (1.9) |
Table 3. Tamponade use for the primary RD surgery failure risk factor model covariates.
SF6 = Sulphur hexafluoride gas.
C2F6 = Perfluoroethane gas.
C3F8 = Perfluoropropane gas.
Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™
This activity is intended for ophthalmologists and other clinicians who treat and manage patients with rhegmatogenous retinal detachment.
The goal of this activity is for learners to be better able to describe variables associated with primary anatomical outcome after vitrectomy and internal tamponade for rhegmatogenous retinal detachment.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 3/27/2023
Valid for credit through: 3/27/2024
processing....
INTRODUCTION: To identify variables associated with primary anatomical outcome following vitrectomy and internal tamponade for rhegmatogenous retinal detachment (RD).
METHODS: A retrospective analysis of prospectively collected data, using a database of RD treated with vitrectomy and internal tamponade. Collected data complied with the RCOphth Retinal Detachment Dataset. The main outcome measure was anatomical failure within six months of surgery.
RESULTS: There were 6377 vitrectomies. 869 eyes were excluded, either because no outcome was recorded, or inadequate follow up, leaving 5508 operations for analysis. 63.9% of patients were male, and the median age was 62. Primary anatomical failure occurred in 13.9%. On multivariate analysis, the following were associated with increased risk of failure: age <45, or >79, inferior retinal breaks, total detachment, one quadrant or greater inferior detachment, low density silicone oil, and presence of proliferative vitreoretinopathy. C2F6 tamponade, cryotherapy, and 25 G vitrectomy, were associated with reduced risk of failure. The area under the receiver operator curve was 71.7%. According to this model, 54.3% of RD are at low risk (<10%), 35.6% are at moderate risk (10–25%), and 10.1% are at high risk (>25%) of failure.
CONCLUSIONS: Previous attempts to identify high risk RD have been limited by small numbers, the inclusion of both scleral buckling and vitrectomy, or by excluding some types of RD. This study examined outcomes in unselected RD, treated by vitrectomy. Identification of the variables associated with anatomical outcome after RD surgery enables accurate risk stratification, which is valuable for patient counselling and selection, and for future clinical trials.
Some of the factors that affect anatomical success after retinal detachment (RD) surgery are relatively well understood, and grading systems have been produced that enable surgeons to predict the likelihood of anatomical re-attachment with a single operation[1–6]. However, some of these publications include both scleral buckling and vitrectomy[1, 4, 7, 8] The risk factors for failure are unlikely to be the same for these very different operations. Other reports have only included sub-sets of primary retinal detachments[3, 7], or have included re-operations[8]. Various different outcomes and definitions of anatomical success have been used[4, 5, 8]. Overall, the number of eyes included in each study has been small, Q1 -Q5 with only one report including more than 1 000 eyes[8].
Previous authors have shown that the risk of primary anatomical failure may be increased by proliferative vitreoretinopathy (PVR)[3–6, 8], a greater extent of retinal detachment[3, 4, 9], foveal detachment[10] or total detachment[5, 8], the number of breaks in detached retina[5, 7], inferior breaks[5], the size of breaks[7], pseudophakia[3], hypotony or choroidal detachment[8], and the use of cryotherapy[7]. It is not surprising that there is little agreement between these studies, given the different inclusion criteria, interventions, and end-points, and the relatively small numbers of cases included.
In order to identify, and quantify, the variables associated with anatomical outcome of primary RD treated by pars plana vitrectomy and internal tamponade, we examined data from 5508 primary RD operations. In contrast to some of the other studies of risk factors, we included all primary rhegmatogenous RD, and used the outcome of primary anatomical failure, as this has been shown to be associated with worse functional outcomes.[11, 12]